Behind the scenesheartwire
Editorial programs
Academic collaboration
Late-breaking clinical trial schedule
Download as PDF Hot line I: Late-breaking trials on prevention of heart failure
Sunday, August 26, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: Gordon Tomaselli (Johns Hopkins University, Baltimore, MD), Michel Komajda (Groupe Hospitalier Pitié-Salpêtrière, Paris, France)
Sunday, August 26, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: Gordon Tomaselli (Johns Hopkins University, Baltimore, MD), Michel Komajda (Groupe Hospitalier Pitié-Salpêtrière, Paris, France)
 |
|
PURE: Patterns of risk factor prevalence for CVD globally by urbanization, gender, and economic status of countries and individuals: The Prospective Urban Rural Epidemiologic (PURE) study of 153 996 people from 628 communities in 17 countries Sunday, August 26 11:00 AM Salim Yusuf (McMaster University, Hamilton, ON) Discussion 11:10 AM (David A Wood, Imperial College London, UK) |
|
DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography Sunday, August 26 11:15 AM James Min (Cedars Sinai Medical Center, Los Angeles, CA) Discussion 11:25 AM (Jean-Pierre Bassand, University Hospital Jean-Minjoz, Besançon, France) |
|
|
ALTITUDE: Aliskiren Trial in Type 2 Diabetes Using Cardiorenal End Points Sunday, August 26 11:30 AM Hans-Henrik Parving (Rigshospitalet, Copenhagen, Denmark) Discussion 11:40 AM (Adriaan Voors, University Medical Center Groningen, the Netherlands) |
|
|
TRILOGY-ACS: Prasugrel versus clopidogrel for patients with unstable angina/NSTEMI who are medically managed without revascularization Sunday, August 26 11:45 AM Matthew T Roe (Duke University, Durham, NC) Discussion 11:55 AM (Raffaele De Caterina, Gabriele d'Annunzio University, Chieti, Italy) |
|
|
PARAMOUNT: Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in patients with heart failure and preserved ejection fraction: Primary results from the PARAMOUNT study Sunday, August 26 12:00 noon Scott Solomon (Brigham and Women's Hospital, Boston, MA) Discussion 12:10 PM (Piotr Ponikowski, Medical University, Clinical Military Hospital, Wroclaw, Poland) |
|
|
Aldo-DHF: Aldosterone Receptor Blockade in Diastolic Heart Failure Sunday, August 26 12:15 PM Burkert Pieske (Medical University of Graz, Austria) Discussion 12:25 PM (John GF Cleland, Hull York Medical School, University of Hull, UK) |
Hot line II: Late-breaking trials on interventions
August 27, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: Michael Böhm (Saarland University Hospital, Homburg/Saar, Germany), Fausto Pinto (Lisbon University, Portugal)
August 27, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: Michael Böhm (Saarland University Hospital, Homburg/Saar, Germany), Fausto Pinto (Lisbon University, Portugal)
|
IABP-SHOCK II: Randomized comparison of intra-aortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock Monday, August 27 11:00 AM Holger Thiele (University of Leipzig, Germany) Discussion 11:10 AM (Uta C Hoppe, Paracelsus Medical University Salzburg, Austria) |
|
|
PROTECT: Primary Results from PROTECT: the Patient Related Outcomes with Endeavor versus Cypher Stenting Trial Monday, August 27 11:15 AM Dr William Wijns (Cardiovascular Center Aalst, Belgium) Discussion 11:25 AM Stephan Windecker (University of Bern, Switzerland) |
|
|
GARY: German Aortic Valve Registry—in-hospital outcome Monday, August 27 11:30 AM Christian W Hamm (Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany) Discussion 11:40 AM (Olaf Wendler, King's College Hospital, London, UK) |
|
|
ACCESS-EUROPE—An observational study of the MitraClip system in Europe Monday, August 27 11:45 AM Wolfgang Schillinger (Universitätsklinik Göttingen, Germany) Discussion 11:55 AM Simon Ray (South Manchester University Hospitals, UK) |
|
|
FAST-MI program: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys over 15 years. Monday, August 27 12:00 noon Nicolas Danchin (Hospital European Georges Pompidou, Paris, France) Discussion 12:10 PM (Filippo Crea, Catholic University of Sacred Heart, Rome, Italy) |
|
|
GRACE: Effects of insulin glargine and of polyunsaturated fatty acids on carotid intima media thickness in high-risk diabetes Monday, August 27 12:15 PM Eva Lonn (McMaster University, Hamilton, ON) Discussion 12:25 PM (John E Deanfield, University College London, UK) |
Hot line III: Late-breaking trials on arrhythmias and CAD
August 28, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: David Holmes (Mayo Clinic, Rochester, MN), Keith Fox (Edinburgh Centre for Cardiovascular Sciences, Scotland)
August 28, 2012, 11:00 AM – 12:30 PM
Hot Line, Webcast
Munich—Central Village
Chairperson: David Holmes (Mayo Clinic, Rochester, MN), Keith Fox (Edinburgh Centre for Cardiovascular Sciences, Scotland)
|
|
PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with maze versus cardiac surgery without maze in patients with coronary and/or valvular heart disease and with atrial fibrillation Tuesday, August 28 11:00 AM Petr Widimsky (Charles University, Prague, Czech Republic) Discussion 11:10 AM (Dr Richard Cappato, IRCCS Policlinico San Donato, Milan, Italy) |
|
WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI) Tuesday, August 28 11:15 AM Willem Dewilde (TweeSteden Hospital, the Netherlands) Discussion 11:25 AM (Marco Valgimigli, University of Ferrara, Italy) |
|
|
AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the atrial fibrillation ablation conducted by the European Heart Rhythm Association Tuesday, August 28 11:30 AM Elena Arbelo (University of Barcelona, Spain) Discussion 11:40 AM (Christophe Leclercq, Centre Hospitalier Universitaire De Rennes, France) |
|
|
The Great East Japan Earthquake Disaster and Cardiovascular Diseases Tuesday, August 28 11:45 AM Hiroaki Shimokawa (Tohoku University Graduate School of Medicine, Sendai, Japan) Discussion 11:55 AM (Gerhard Steinbeck, Ludwig-Maximilians University, Munich, Germany) |
|
|
CORE320: Diagnostic Performance of Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-row Detector Computed Tomography: The CORE320 Multicenter, Multinational Study Tuesday, August 28 12:00 noon João Lima (Johns Hopkins University, Baltimore, MD) Discussion 12:10 PM (Gerald Maurer, Medical University of Vienna, Austria) |
|
|
FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease Tuesday, August 28 12:15 PM Bernard De Bruyne (OLV Clinic, Aalst, Belgium) Discussion 12:25 PM (Frans Van de Werf, University of Leuven, Belgium) |
